AI-Driven Pathology: A New Era of Precision Clinical Trials
PathAI emerges as an enterprise transforming clinical trials with groundbreaking precision in the dynamic field of AI-driven pathology. Ben...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
PathAI emerges as an enterprise transforming clinical trials with groundbreaking precision in the dynamic field of AI-driven pathology. Ben...
As clinical trial complexity continues to rise, effective technology is paramount. In this interview, we discussed clinical trial technology...
At the 2024 SCOPE Summit, Demetris Zambas, VP and Global Head of Data Monitoring and Management at Pfizer explored...
PhotoPharmics, in partnership with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center (URMC),...
TriSalus Life Sciences® Inc., an oncology company specializing in novel delivery technologies combined with immunotherapy for liver and pancreatic...
Volastra Therapeutics, a clinical-stage biotechnology company at the forefront of developing cancer treatments targeting chromosomal instability (CIN), has announced...
Bristol Myers Squibb (BMY) has launched a $1.8 million initiative to advance health equity by addressing the social determinants...
In the fast-changing world of pharmaceutical drug development, new digital twin technologies are beginning to make a significant impact....
Arrowhead Pharmaceuticals, Inc. has launched an Expanded Access Program (EAP) to offer plozasiran, its investigational therapy, to patients with...
Actylis and Novo Nordisk Pharmatech A/S have partnered to distribute pharmaceutical-grade Benzalkonium Chloride (BKC) in key European markets, including...